Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lunai Bioworks Inc. Director's Dealing 2021

Nov 23, 2021

34813_dirs_2021-11-23_2fd0b6a4-93d7-4f09-a9ce-dbb2a3623815.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Enochian Biosciences Inc (ENOB)
CIK: 0001527728
Period of Report: 2021-10-26

Reporting Person: Puche Luisa (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-10-26 Option to purchase shares of common stock $8.58 A 60000 Acquired 2031-10-26 Common stock (60000) Direct

Footnotes

F1: The options vest ratably on October 26, 2022, October 26, 2023 and October 26, 2024.